ERBB2 and cancer: HER2 signalling controls expression of the oncogenic miR-21-5p and HER2 overexpression has been shown to induce mir-21 transcription in normal and cancer cells4, either directly or via transcriptional activation of the neighbouring VMP1 gene that can bypass polyadenylation signals to include the mir-21 precursor5.